Exova Health Sciences first manufacturing facility Gets MHRA Approval

The new purpose-built state of the art manufacturing and packaging facility for the supply of products for clinical trials at Exova Prova in Camberley, Surrey has received approval from the MHRA.

The new clinical supplies areas operate to GMP (good manufacturing practice) and specialise in the manufacture of investigational medicinal products for early phase clinical studies.

The company has moved into the field of manufacture to complement its existing contract pharmaceutical development services, including formulation, analytical and regulatory to the pharmaceutical and biotech industries. Exova Prova is now able to offer a ‘one stop shop’ service, from the early phase development of products to the manufacture of capsules, oral solutions and suspensions, creams, gels and ointments. Additional services in packaging, labeling advice as well as dispatch and shipping are now offered too.

With sites in Europe and North America, Exova Health Sciences offers a truly global pharma capability with its laboratories providing reliable, independent, development, analytical and regulatory services to the pharmaceutical and healthcare sectors. A responsive, flexible approach and comprehensive support provides a true value-added service for both the smaller high-tech/biotech companies and for the larger pharmaceutical organisations.